Search Results - "Akamatsu, Shusuke"

PARP Inhibition in Prostate Cancer: Current Status, Resistance Mechanisms, and Clinical Challenges.

Authors: Matsuoka, Takashi Akamatsu, Shusuke Ong, Christopher J. et al.

Source: Cells (2073-4409). Apr2026, Vol. 15 Issue 7, p588. 24p.

Editorial Comment to "Geriatric Nutritional Risk Index Predicts Postoperative Complications in Elderly Patients Undergoing Robot‐Assisted Radical Cystectomy".

Authors: Zennami, Kenji Akamatsu, Shusuke

Source: International Journal of Urology. Aug2025, Vol. 32 Issue 8, p951-952. 2p.

Active Surveillance in Prostate Cancer With Intermediate‐Risk Features: The PRIAS‐JAPAN Study.

Authors: Blas, Leandro Shiota, Masaki Kato, Takuma et al.

Source: International Journal of Urology. Jul2025, Vol. 32 Issue 7, p823-827. 5p.

In This Issue.

Authors: Akamatsu, Shusuke¹ (AUTHOR) akamatsu.shusuke.n8@f.mail.nagoya‐u.ac.jp

Source: International Journal of Urology. Jun2025, Vol. 32 Issue 6, p619-620. 2p.

Total pelvic exenteration for mucinous adenocarcinoma arising from an implantation cyst 26 years after surgery for rectal cancer.

Authors: Fujita, Yusuke Itatani, Yoshiro Kawada, Kenji et al.

Source: Asian Journal of Endoscopic Surgery. Jul2023, Vol. 16 Issue 3, p558-562. 5p.

Triplet therapy for metastatic castration‐sensitive prostate cancer: Rationale and clinical evidence.

Authors: Suzuki, Hiroyoshi Akamatsu, Shusuke Shiota, Masaki et al.

Source: International Journal of Urology. Mar2025, Vol. 32 Issue 3, p239-250. 12p.

Efficacy and safety of combination immunotherapy for treating advanced non-clear cell renal cell carcinoma: A multicenter retrospective study in Japan.

Authors: Iinuma, Koji Sano, Yuta Nishikawa, Kohei et al.

Source: Scientific Reports. 10/10/2025, Vol. 15 Issue 1, p1-11. 11p.

Local Therapy Can Enhance the Prognosis of Certain Patients with Pathologically Diagnosed Neuroendocrine Prostate Carcinoma.

Authors: Kimura, Shoichi Terada, Naoki Soumiya, Shinnya et al.

Source: Life (2075-1729). May2025, Vol. 15 Issue 5, p797. 9p.

Author Index: International Journal of Urology 2006.

Source: International Journal of Urology. Dec2006, Vol. 13 Issue 12, p1550-1563. 14p.

Development and validation of a nomogram (APGRC) to predict the presence of germline DNA damage repair pathogenic variants in Asian patients with prostate cancer.

Authors: Zhang, Tingwei Wei, Yu Hong, Boon Hao et al.

Source: Clinical & Translational Medicine. Sep2023, Vol. 13 Issue 9, p1-6. 6p.

Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study.

Authors: Suzuki, Shuhei Negoro, Hiromitsu Kubota, Masashi et al.

Source: Scientific Reports. 1/15/2025, Vol. 15 Issue 1, p1-10. 10p.

Author Correction: Comprehensive genomics in androgen receptor-dependent castration-resistant prostate cancer identifies an adaptation pathway mediated by opioid receptor kappa 1.

Authors: Makino, Yuki Kamiyama, Yuki Brown, J. B. et al.

Source: Communications Biology. 7/19/2022, Vol. 5 Issue 1, p1-1. 1p.

This Issue 30‐10.

Authors: Akamatsu, Shusuke¹ (AUTHOR)

Source: International Journal of Urology. Oct2023, Vol. 30 Issue 10, p807-807. 1p.

Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort.

Authors: Kato, Masashi Shiota, Masaki Kimura, Takahiro et al.

Source: International Journal of Urology. Jun2024, Vol. 31 Issue 6, p662-669. 8p.

The Roles of Extracellular Vesicles in the Progression of Renal Cell Carcinoma and Their Potential for Future Clinical Application.

Authors: Takeda, Masashi Akamatsu, Shusuke Kita, Yuki et al.

Source: Nanomaterials (2079-4991). May2023, Vol. 13 Issue 10, p1611. 18p.

Subjects: Renal cell carcinoma, Extracellular vesicles, Clinical medicine, Extracellular space, Renal cancer, Polymersomes

A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma.

Authors: Fukui, Tomohiro Okasho, Kosuke Okuno, Yukiko et al.

Source: Cancer Medicine. Mar2025, Vol. 14 Issue 5, p1-12. 12p.

Renal cell carcinoma with multiple bone metastases effectively treated by a combination of tyrosine kinase inhibitor, robot‐assisted partial nephrectomy, and metastasectomy.

Authors: Sawada, Atsuro Takeda, Masashi Goto, Takayuki et al.

Source: Clinical Case Reports. Mar2024, Vol. 12 Issue 3, p1-6. 6p.

Rapidly Progressive Bladder Cancer Diagnosed because of Spontaneous Bladder Rupture.

Authors: Hagimoto, Hiroki Sano, Takeshi Kashima, Soki et al.

Source: Case Reports in Urology. 5/9/2022, p1-7. 7p.

Clinical factors for tumor response, progression, and survival in nivolumab for advanced renal cell carcinoma in the SNiP‐RCC study.

Authors: Blas, Leandro Shiota, Masaki Miyake, Hideaki et al.

Source: International Journal of Urology. Sep2023, Vol. 30 Issue 9, p788-796. 9p.

Analysis of trifecta outcomes in a single center with robot‐assisted partial nephrectomy for T1b renal tumors.

Authors: Masui, Kimihiko Matsuoka, Takashi Kono, Jin et al.

Source: Asian Journal of Endoscopic Surgery. Jul2023, Vol. 16 Issue 3, p441-446. 6p.